title: Novel French antidepressants not available in the United States.
abstract: There is little awareness in the United States and other English-speaking countries of a number of novel antidepressant drugs that have recently been developed and marketed in France. This review focuses on tianeptine, amineptine, minaprine, medifoxamine, and modafinil--examining both their pharmacological actions and their clinical efficacies. Their potential for further research or marketing in the United States is discussed.
authors.affiliation: School of Psychiatry, University of New South Wales, Sydney, Australia. phil.mitchell@unsw.edu.au
authors.forename: P B
authors.initials: PB
authors.lastname: Mitchell
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D005602:France; D006801:Humans; D013841:Thiazepines / Q000494:pharmacology*; D014481:United States
chemical_list: D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes; D013841:Thiazepines; C050504:tianeptine; C011597:amineptin